Document:

Nondisclosure Agreement

Nondisclosure Agreement

This agreement (“Agreement”) is entered into and effective as of 6th day of February, 2007, between Precision Metal Manufacturing, Inc (a Colorado Corporation) located at 12555 West 52nd Avenue, Arvada, Colorado 80002 and Back 2 Health, Ltd. located at 5373 North Union Bvld., Colorado Springs, Colorado  80918 (hereinafter collectively referred to as “the Parties”).

WHEREAS, the Parties contemplate entering into a business relationship regarding materials production: and 

WHEREAS, Back 2 Health, Ltd. needs to disclose certain information to Precision Metal Manufacturing, Inc. regarding the potential business relationship:

NOW THEREFORE, in consideration of the disclosure of Proprietary Information (as defined herein) to Precision Metal Manufacturing, Inc. the Parties agree as follows:

1.

Definition:

“Information” is defined as communications or data including, but not limited to, business information, marketing plans, technical or financial information, customer lists or proposals, trademark filings, patent applications, sketches, models, samples, drawings, specifications, whether conveyed in oral, written, graphic, or electromagnetic form or otherwise.

“Party” is defined as either entity executing this Agreement and any subsidiary, division, or parent company of such entity.

“Proprietary Information” is defined as that information owned or possessed by Back 2 Health Ltd. that Back 2 Health, Ltd. desires to protect as confidential against unrestricted disclosure or improper competitive use, and that is designated as such in the manner provided by this Agreement.

2.

All information that is disclosed by Back 2 Health, Ltd. (“Disclosing Party”) to Precision Metal Manufacturing, Inc. (“Receiving Party”) and that is to be protected hereunder by the Receiving Party as Proprietary Information:

(a)  in writing or other tangible form, shall be conspicuously labeled as “proprietary”,  “confidential”, or with words of similar importance at the time of delivery; and

(b)  if oral, shall concern only topics and scope agreed in advance, in writing, and shall be identified as “proprietary” or “confidential” prior to disclosure, and after disclosure shall be summarized in writing or other tangible form promptly, but in no event later than twenty (20) business days thereafter, and the summary shall be delivered to the Receiving Party consistent with Subparagraph 2(a) hereof.

3.

Proprietary Information of the Disclosing Party shall remain the property of the Disclosing Party.  Proprietary Information of the Disclosing Party shall be treated and safeguarded hereunder by the Receiving Party for a period of five (5) years from the date of disclosure.  The Receiving Party warrants that it applies reasonable safeguards against the unauthorized disclosure of Proprietary Information and that it will protect such Proprietary Information at least as securely as it protects it own Proprietary Information.

4.

The Receiving Party agrees that (i) the documents provided to the Receiving Party hereunder containing Proprietary Information of the Disclosing Party shall be used by the Receiving Party solely for the purpose of evaluating its interest in the business arrangements described or performing a future 

agreement between the parties; (ii) it will not use such documents disclosed hereunder for any other purpose; and (iii) it will not distribute, disclose, or disseminate Proprietary Information to anyone except its employees with a need to know who are involved in the consideration or performance of the business arrangements described herein.

5.

This Agreement shall not apply to Information that:

(a)

is in or enters the public domain, through no fault of the Receiving Party; or

(b)

is or has been disclosed by the Disclosing Party to the other Party or the third party without restriction; or

(c)

is already in the possession of the Receiving Party, without restriction and prior to disclosure of the information hereunder; or 

(d)

is or has been lawfully disclosed by a third party to the Receiving Party without an obligation of confidentiality; or

(e)

is developed by the Receiving Party independently of any breach of this Agreement; or

(f)

the applicable period of confidentiality pursuant to Paragraph 3 has ended.

Each Party may disclose any Proprietary Information to the extent that such Party has been advised by counsel that such disclosure is necessary to comply with the laws or regulations, provided that each Party shall give the other Party reasonable advance notice of such proposed disclosure, shall use its best efforts to assist Disclosing Party to secure confidential treatment of any such Proprietary Information and shall advise the other Party in writing of the manner of the disclosure.

6.

This Agreement shall terminate five (5) years from the date first written above, or upon ten (10) days written notice by either Party except the obligations of confidentiality pursuant to Paragraph 3, and the terms of Paragraph 4, shall continue for the period specified in Paragraph 3.

7.

Neither this Agreement nor the disclosure or receipt of Information shall constitute or imply a commitment by either Party with respect to present or future business arrangements or other subject matter not expressly set forth herein.

8.

The Receiving Party shall have, or shall enter into, agreements with its parent, divisions, subsidiary companies, and consultants that will safeguard the Proprietary Information disclosed hereunder consistent with the terms of this Agreement.  With respect to employees, the Receiving Party shall advise all employees who will have access to Proprietary Information as to their obligations contained herein.

9.

Except as expressly provided herein, no license or right is granted by the Disclosing Party to the Receiving Party under any patent, patent application, trademark, copyright, software, or trade secret.

10.

Any amendment to this Agreement must be in writing and signed by authorized officers of each Party.  No failure or delay in exercising any right under this Agreement shall operate as a waiver thereof.

11.

At the Disclosing Party’s request, all Proprietary Information of the Disclosing Party in tangible form that is in the possession of the Receiving Party shall be returned to the Disclosing Party or destroyed.

12.

Each Party agrees that it will not disclose the subject matter or terms of this Agreement or the discussions between the Parties without the written consent of the other Party.

13.

This Agreement shall be governed by the laws of the State of Colorado.

14.

If any provision of this Agreement shall be deemed invalid, unenforceable, or illegal, or if the period during which this Agreement is to remain effective is found to exceed the legally permissible period, then notwithstanding such invalidity, unenforceability, or illegality the remainder of this Agreement shall continue in full force and effect during the maximum period legally permissible.

15.

A copy of this document may be executed by each party, separately, and when each party has executed a copy thereof, such copies taken together shall be deemed to be a full and complete agreement between the Parties.  Facsimile signatures shall be deemed the equivalent of original signatures.

16.

If a dispute relates to this Agreement, or its breach, and the parties have not been successful in resolving such dispute through negotiation, the parties agree to attempt to resolve the dispute through mediation by submitting the dispute to a sole mediator selected by the parties or, at any time at the option of a party, to arbitration by the American Arbitration Association (“AAA”).  Each party shall bear its own expenses and an equal share of the expenses of the mediator or arbitrator and the fees of the AAA.  All defenses based on passage of time shall be suspended pending the termination of the mediation or arbitration.  Nothing in this clauses shall be construed to preclude any party from seeking injunctive relief in order to protect its rights pending mediation or arbitration.

17.

The Parties have read, agree to, and understand the above conditions.

Back 2 Health, Ltd.

PRECISION METAL MANUFACTURING, INC.

Company Name

/s/John B. Quam

/s/ Brian J. Cirbo

Company Representative Signature 

Company Representative Signature 

John B. Quam

Brian J. Cirbo

Print Company Representative Name

Print Company Representative Name

President

Vice President

Company Representative Title 

Company Representative Title 

02/06/07

02/06/07

Date

DateConverted by EDGARwiz

REDEMPTION AGREEMENT

THIS REDEMPTION AGREEMENT (the "Agreement") is entered into effective as of the ____ day of September, 2006 (the "Closing Date"), by and between B2 HEALTH, INC., a Delaware corporation, ("B2"),  and TRIUMPH CAPITAL, INC., a Colorado corporation,("Triumph").

RECITALS

A.

Triumph is the record and beneficial owner of an aggregate of 62,500 shares of B2 Common Stock (the "B2 Shares" or the "B2 Common Stock").

B.

B2 desires to purchase and redeem and Triumph is willing to sell the B2 Shares in accordance with the terms of this Agreement.

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinbelow set forth, the parties agree as follows:

1.

Purchase and Redemption of  B2 Shares.  Subject to the terms and conditions hereinafter set forth, on the Closing Date (as hereinafter defined) Triumph shall sell, assign, transfer and deliver to B2, and B2 shall purchase and redeem from Triumph, an aggregate of 62,500 of the B2 Shares, against delivery of the Purchase Price as hereinbelow set forth.  Triumph shall deliver to B2 on the Closing Date the certificate evidencing the B2 Shares, which Certificate shall be duly endorsed in blank or accompanied by an irrevocable assignment duly executed in blank, in each case in proper form for transfer.

2.

Purchase Price.  The purchase price for the B2 Shares shall be the aggregate amount of $25,000 (the "Purchase Price").  The Purchase Price shall be payable in cash or certified funds on the Closing Date.

3.

Representations and Warranties of Triumph.  Triumph hereby represents and warrants to B2 as follows:

(a)

Triumph warrants and represents that it is entering into this transaction with B2 freely and voluntarily and in agreeing to sell the B2 Shares is not relying upon any statement by B2, or its officers or directors, about B2 or its capital stock or the value thereof; nor is Triumph relying upon B2, or its officers or directors, as a source of information pertaining to B2 or its stock or the value thereof.  Triumph represents that it has had the opportunity to review materials pertaining to the financial condition of B2 and has been given access to full and complete information regarding B2 and has utilized such access to its satisfaction for the purpose of obtaining such information regarding B2 as Triumph has reasonably requested; and, particularly, Triumph has been given reasonable opportunity to ask questions of and receive answers from representatives of B2 concerning B2's financial condition and results of operations.  The principals of Triumph have such knowledge and experience in financial and business matters that Triumph is able to make an informed investment decision with respect to the sale of the B2 Shares.  Triumph acknowledges that there exists no public trading market for the B2 Shares and that the Purchase Price for the B2 Shares was derived as a result of arm's length negotiations entered into without duress or undue influence.  

(b)

The execution and the delivery of this Agreement and the consummation of the transactions contemplated hereby by Triumph do not conflict with or result in a breach or violation of, or default under (or an event that, with notice or lapse of time, or both, would constitute a default), any of the terms, provisions or conditions of the Articles of Incorporation or By-Laws of the Company, or any material agreement or instrument to which Triumph is a party or by which Triumph is bound.

(c)

This Agreement has been duly authorized by all necessary corporate action on behalf of Triumph and has been duly executed and delivered by authorized officers of Triumph and is a valid and binding agreement on the part of the Triumph that is enforceable against the Triumph in accordance with its terms, except as the enforceability hereof may be limited by bankruptcy, insolvency, moratorium, reorganization or other similar laws affecting the enforcement of creditors' rights generally and to judicial limitations on the enforcement of the remedy of specific performance and other equitable remedies.

(d)

Triumph owns the  B2 Shares, both beneficially and of record, subject to no liens, encumbrances or rights of others, and has the right to transfer to B2 the entire right, title and interest in and to the B2 Shares.

4.

Payment of Expenses.  Each party will be liable for its own costs and expenses incurred in connection with the negotiation, preparation, execution or performance of this Agreement, including without limitation, any legal, accounting, and other professional fees and expenses.

5.

Attorney's Fees for Claims.  In the event that a claim is brought by one party hereto against the other party hereto for breach of any provision hereof or otherwise arising out of the transaction to which this Agreement relates, the prevailing party shall be entitled to payment or reimbursement of the expenses incurred by it in connection with the litigation or the portion thereof as to which it prevails, including but not limited to, attorneys' fees and costs.

6.

Waiver.  Any of the terms or conditions of this Agreement may be waived at any time and from time to time in writing by the party entitled to the benefits thereof without affecting any other terms or conditions of this Agreement.  The waiver by any party hereto of any condition or breach of any provision of this Agreement shall not operate as a waiver of any other condition or other or subsequent breach.

7.

Amendment.  This Agreement may be amended or modified only by a written instrument executed by the parties hereto.

8.

Entire Agreement.  This Agreement sets forth the entire agreement and understanding of the parties in respect of the transactions contemplated hereby and supersedes all prior agreements, arrangements and understandings, oral or written, relating to the subject matter hereof.  No representation, promise, inducement or statement of intention has been made by either party which is not embodied in this Agreement and no party shall be bound by or liable for any alleged representation, promise, inducement or statement of intention not so set forth.

9.

Survival of Representations, Warranties and Agreements.  All representations and warranties contained in this Agreement shall survive the consummation of the transaction contemplated hereby for a period of two years immediately following the Closing Date.  All 

2

agreements and covenants contained in this Agreement not fully performed as of the Closing Date shall survive the Closing Date and continue thereafter until fully performed or until the time for further performance has expired.

10.

Severability.  In case any provision in this Agreement shall be held invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions hereof shall not in any way be affected or impaired thereby.

11.

Third Party Beneficiaries.  Each party hereto intends that this Agreement shall not benefit or create any right or cause of action in or on behalf of any person other than the parties hereto.

12.

Fax/Counterparts.  This Agreement may be executed by telex, telecopy or other facsimile transmission, and may be executed in counterparts, each of which shall be deemed an original, but all of which shall together constitute one agreement.  

13.

Litigation.  Any litigation commenced which is based in whole or in part upon claims under or in connection with this Agreement or the transaction contemplated hereby shall be brought in a court of competent jurisdiction (state or federal) in the United States of America.

14.

General.  This Agreement  shall be construed and enforced in accordance with the laws of the State of Colorado, may not be transferred or assigned by any party hereto, other than by operation of law, and shall inure to the benefit of and be binding upon B2 and Triumph and their respective successors and assigns; and may be executed in two or more counterparts, each of which shall be deemed an original but all of which together shall constitute one and the same instrument.  The section headings contained in this Agreement are for reference purposes only and shall not affect in any way the  meaning or interpretation of this Agreement.

IN WITNESS WHEREOF, the parties have duly executed this Agreement as of the date and year first above written.

B2 HEALTH, INC.,

a Delaware corporation

By:/s/ John Quam

      John Quam, President

TRIUMPH CAPITAL, INC., a Colorado corporation

By: /s/ Stephen G. Calandrella

       Stephen G. Calandrella, President

3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]